Udenafil
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Mezzion Pharma Co. Ltd
Overview
Udenafil is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Udenafil clinical trials
Explore related
Medical disclaimer. This page summarizes research about Udenafil for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.